tert-Butyl benzo[b]thiophen-2-ylcarbamate, 95.0%, 5g

N-Acetyl-D-mannosamine, min. 98%, 1 g, glass packaging

6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide, 98.00%, 100mg

4-(2-(4-Bromophenyl)-1,2-diphenylvinyl)phenol, 97%, 250mg

2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2), 98%, 1g

2-Methyl-oxazole-4-carbaldehyde, 98.0%, 100mg

2-(Difluoromethyl)quinoline, 97%, 5g

(R,S)-tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate, 95.0%, 25g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyridine, 95.0%, 5g

tert-butyl 4-(3-isopropyl-2,5-dioxopiperazin-1-yl)piperidine-1-carboxylate, 250mg

4-Bromo-2-iodophenol, 95.0%, 10g

2,3-Difluoro-4-methoxybenzoic acid, 97.0%, 1g

Ethyl Pyridine-2-carboxylate>98.0%(GC)25g